Saravia Bermeo Isabel Cristina, Ramírez-Guerrero Gonzalo, Angulo Juliao Milene, Molina Comboni Daniel, Bueno Lara Cristhian, Zapata Zapata Maria Adelaida
Medical Affairs, Vantive Colombia and South Latin America, Bogota, Colombia.
Dialysis and Nephrology Unit, Carlos Van Buren Hospital, Valparaiso, Chile.
Blood Purif. 2025 Jun 18:1-9. doi: 10.1159/000546598.
For patients requiring renal replacement therapy, peritoneal dialysis (PD) offers an alternative to maintain quality of life. The long-term success of PD depends on using a safe, functional, and durable peritoneal catheter (PC). This study aimed to assess the outcomes of a training program for nephrologists on PD catheter insertion in South American dialysis centers.
This longitudinal, retrospective, multicenter study was conducted in Colombia, Chile, Ecuador, and Bolivia. Patients who underwent PC insertion between January 2022 and May 2023 were included, with procedures performed by nephrologists trained in a specialized program. Data on population characteristics, procedural details, and catheter function at the first, third, and sixth months were collected.
A total of 117 subjects were included (median age 59 years, 50.4% men). Hypertension and diabetes were the primary causes of kidney disease (34.19% and 49.57%, respectively). Bladder emptying and prophylactic antibiotics were administered before the procedure. Most PC insertions (86.32%) were performed under local anesthesia, with the modified Seldinger technique. Catheter implantation was successful in 96.58% of cases. Elective PD was performed in 69.91% of patients, while 30.01% required urgent PD. Within the first 2 weeks, complications occurred in 7.08% of patients, including catheter tip migration and flow failure. At one, three, and 6 months of follow-up, complications were observed in 1.79%, 3.77%, and 11.00% of patients, respectively. Catheter patency was maintained in 99.10%, 96.22%, and 96.00% of patients at 1, 3, and 6 months, respectively.
Optimal peritoneal access can be achieved through educational programs for nephrologists on catheter insertion, ensuring proper placement and maintenance, and resulting in low complication rates in PD patients.
对于需要肾脏替代治疗的患者,腹膜透析(PD)为维持生活质量提供了一种替代方案。腹膜透析的长期成功取决于使用安全、功能良好且耐用的腹膜导管(PC)。本研究旨在评估南美洲透析中心针对肾病学家开展的腹膜透析导管插入培训项目的效果。
本纵向、回顾性、多中心研究在哥伦比亚、智利、厄瓜多尔和玻利维亚进行。纳入2022年1月至2023年5月期间接受腹膜透析导管插入术的患者,手术由接受过专门培训项目的肾病学家进行。收集了患者的人口统计学特征、手术细节以及术后第1、3和6个月时导管功能的数据。
共纳入117名受试者(中位年龄59岁,男性占50.4%)。高血压和糖尿病是肾病的主要病因(分别占34.19%和49.57%)。术前进行了膀胱排空和预防性抗生素治疗。大多数腹膜透析导管插入术(86.32%)在局部麻醉下采用改良Seldinger技术进行。导管植入成功率为96.58%。69.91%的患者进行了择期腹膜透析,而30.01%的患者需要紧急腹膜透析。在术后前2周内,7.08%的患者出现并发症,包括导管尖端移位和引流不畅。在随访的第1、3和6个月,分别有1.79%、3.77%和11.00%的患者出现并发症。在第1、3和6个月时,分别有99.10%、96.22%和96.00%的患者导管保持通畅。
通过针对肾病学家开展导管插入培训项目,可实现最佳的腹膜通路,确保导管正确放置和维护,从而使腹膜透析患者的并发症发生率较低。